Chugai Pharmaceutical Co Ltd
TSE:4519
Chugai Pharmaceutical Co Ltd
TSE:4519
Price:
7 520
JPY
0.07%
Market Closed
Market Cap:
12.6T
JPY
Income Statement
Earnings Waterfall
Chugai Pharmaceutical Co Ltd
Chugai Pharmaceutical Co Ltd
|
Revenue
|
1.2T
JPY
|
|
Cost of Revenue
|
-354.3B
JPY
|
|
Gross Profit
|
867.8B
JPY
|
|
Operating Expenses
|
-289.1B
JPY
|
|
Operating Income
|
578.8B
JPY
|
|
Other Expenses
|
-168.6B
JPY
|
|
Net Income
|
410.1B
JPY
|
Income Statement
Chugai Pharmaceutical Co Ltd
Chugai Pharmaceutical Co Ltd
Currency: JPY
Millions
TTM
| Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
454 147
N/A
|
479 265
+6%
|
495 454
+3%
|
498 840
+1%
|
501 650
+1%
|
506 193
+1%
|
492 585
-3%
|
491 781
0%
|
497 355
+1%
|
497 024
0%
|
517 909
+4%
|
534 199
+3%
|
556 158
+4%
|
566 547
+2%
|
572 994
+1%
|
579 787
+1%
|
586 649
+1%
|
614 950
+5%
|
662 198
+8%
|
686 184
+4%
|
711 320
+4%
|
734 019
+3%
|
753 853
+3%
|
786 946
+4%
|
776 339
-1%
|
809 054
+4%
|
887 918
+10%
|
999 759
+13%
|
1 191 276
+19%
|
1 205 477
+1%
|
1 739 444
+44%
|
1 259 726
-28%
|
1 807 578
+43%
|
1 839 383
+2%
|
1 276 049
-31%
|
1 111 367
-13%
|
1 036 075
-7%
|
1 084 569
+5%
|
1 142 350
+5%
|
1 170 611
+2%
|
1 222 121
+4%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(220 314)
|
(232 689)
|
(239 469)
|
(240 238)
|
(243 680)
|
(248 031)
|
(245 378)
|
(247 944)
|
(247 929)
|
(244 359)
|
(250 590)
|
(254 171)
|
(256 834)
|
(261 796)
|
(262 676)
|
(262 847)
|
(262 925)
|
(261 758)
|
(269 834)
|
(264 732)
|
(263 434)
|
(269 931)
|
(265 269)
|
(273 465)
|
(267 530)
|
(265 020)
|
(299 856)
|
(337 680)
|
(397 233)
|
(408 997)
|
(568 146)
|
(476 251)
|
(707 403)
|
(719 242)
|
(534 155)
|
(412 650)
|
(334 928)
|
(331 206)
|
(337 168)
|
(337 854)
|
(354 282)
|
|
| Gross Profit |
233 833
N/A
|
246 576
+5%
|
255 985
+4%
|
258 602
+1%
|
257 970
0%
|
258 162
+0%
|
247 207
-4%
|
243 837
-1%
|
249 426
+2%
|
252 665
+1%
|
267 319
+6%
|
280 028
+5%
|
299 324
+7%
|
304 751
+2%
|
310 318
+2%
|
316 940
+2%
|
323 724
+2%
|
353 192
+9%
|
392 364
+11%
|
421 452
+7%
|
447 886
+6%
|
464 088
+4%
|
488 584
+5%
|
513 481
+5%
|
508 809
-1%
|
544 034
+7%
|
588 062
+8%
|
662 079
+13%
|
794 043
+20%
|
796 480
+0%
|
1 171 298
+47%
|
783 475
-33%
|
1 100 175
+40%
|
1 120 141
+2%
|
741 894
-34%
|
698 717
-6%
|
701 147
+0%
|
753 363
+7%
|
805 182
+7%
|
832 757
+3%
|
867 839
+4%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(168 313)
|
(170 624)
|
(172 202)
|
(171 818)
|
(171 883)
|
(171 075)
|
(168 847)
|
(166 953)
|
(166 250)
|
(172 193)
|
(172 837)
|
(181 094)
|
(188 373)
|
(186 349)
|
(189 705)
|
(192 617)
|
(191 669)
|
(200 386)
|
(205 075)
|
(206 939)
|
(210 972)
|
(207 914)
|
(211 546)
|
(211 298)
|
(216 022)
|
(222 754)
|
(231 315)
|
(233 840)
|
(248 950)
|
(248 158)
|
(360 966)
|
(249 525)
|
(363 346)
|
(370 397)
|
(269 469)
|
(253 785)
|
(259 906)
|
(266 656)
|
(265 004)
|
(284 957)
|
(289 060)
|
|
| Selling, General & Administrative |
(86 853)
|
(87 367)
|
(86 211)
|
(88 018)
|
(87 772)
|
(86 313)
|
(85 480)
|
(81 941)
|
(81 247)
|
(82 463)
|
(82 410)
|
(88 147)
|
(89 630)
|
(89 710)
|
(91 553)
|
(93 416)
|
(92 379)
|
(97 894)
|
(99 844)
|
(100 676)
|
(102 068)
|
(96 920)
|
(95 498)
|
(92 992)
|
(94 547)
|
(96 491)
|
(98 993)
|
(100 754)
|
(105 418)
|
(105 496)
|
(150 509)
|
(99 583)
|
(144 650)
|
(154 757)
|
(112 574)
|
(111 916)
|
(114 150)
|
(108 201)
|
(108 439)
|
(109 733)
|
(110 749)
|
|
| Research & Development |
(81 459)
|
(83 257)
|
(85 990)
|
(83 799)
|
(84 111)
|
(84 761)
|
(83 366)
|
(85 011)
|
(85 000)
|
(89 728)
|
(90 426)
|
(92 947)
|
(98 743)
|
(96 638)
|
(98 150)
|
(99 202)
|
(99 289)
|
(102 491)
|
(105 231)
|
(104 733)
|
(108 903)
|
(110 995)
|
(116 049)
|
(116 601)
|
(121 477)
|
(126 265)
|
(132 324)
|
(131 276)
|
(141 282)
|
(141 538)
|
(209 398)
|
(148 059)
|
(221 028)
|
(231 539)
|
(172 891)
|
(169 061)
|
(172 867)
|
(171 475)
|
(170 981)
|
(176 744)
|
(181 013)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1 530)
|
0
|
0
|
0
|
(1 705)
|
0
|
0
|
0
|
(1 810)
|
0
|
0
|
0
|
(1 820)
|
0
|
0
|
0
|
(1 369)
|
0
|
0
|
0
|
(818)
|
0
|
|
| Other Operating Expenses |
0
|
0
|
(1)
|
(1)
|
0
|
(1)
|
(1)
|
(1)
|
(3)
|
(2)
|
(1)
|
0
|
0
|
(1)
|
(2)
|
1
|
0
|
(1)
|
0
|
0
|
0
|
1
|
0
|
0
|
2
|
2
|
0
|
0
|
(2 250)
|
(1 124)
|
(1 059)
|
(63)
|
2 332
|
15 899
|
15 996
|
28 561
|
27 111
|
13 020
|
14 416
|
2 338
|
2 702
|
|
| Operating Income |
65 520
N/A
|
75 952
+16%
|
83 783
+10%
|
86 784
+4%
|
86 087
-1%
|
87 087
+1%
|
78 360
-10%
|
76 884
-2%
|
83 176
+8%
|
80 472
-3%
|
94 482
+17%
|
98 934
+5%
|
110 951
+12%
|
118 402
+7%
|
120 613
+2%
|
124 323
+3%
|
132 055
+6%
|
152 806
+16%
|
187 289
+23%
|
214 513
+15%
|
236 914
+10%
|
256 174
+8%
|
277 038
+8%
|
302 183
+9%
|
292 787
-3%
|
321 280
+10%
|
356 747
+11%
|
428 239
+20%
|
545 093
+27%
|
548 322
+1%
|
810 332
+48%
|
533 950
-34%
|
736 829
+38%
|
749 744
+2%
|
472 425
-37%
|
444 932
-6%
|
441 241
-1%
|
486 707
+10%
|
540 178
+11%
|
547 800
+1%
|
578 779
+6%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
554
|
628
|
350
|
623
|
149
|
135
|
584
|
1 262
|
632
|
468
|
318
|
4
|
8
|
35
|
(74)
|
444
|
609
|
614
|
406
|
519
|
(407)
|
1
|
(523)
|
(1 575)
|
(606)
|
(777)
|
403
|
56
|
1 355
|
1 819
|
2 009
|
769
|
2 130
|
2 737
|
3 008
|
4 240
|
3 297
|
2 397
|
39
|
323
|
195
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(64)
|
0
|
0
|
0
|
(160)
|
0
|
0
|
0
|
(97)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3 916)
|
0
|
0
|
0
|
(953)
|
0
|
0
|
0
|
(6 342)
|
(156)
|
(156)
|
(488)
|
(641)
|
(5 284)
|
(5 525)
|
(5 353)
|
(5 758)
|
(489)
|
(248)
|
0
|
(5 798)
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
(67)
|
0
|
1
|
0
|
(3 538)
|
(4 539)
|
(3 884)
|
(4 558)
|
(1 810)
|
(1 230)
|
(2 817)
|
(2 729)
|
(3 318)
|
(3 447)
|
(3 186)
|
(3 300)
|
(3 223)
|
(2 820)
|
(2 498)
|
(2 062)
|
(1 467)
|
(968)
|
(625)
|
(3 155)
|
(2 568)
|
(4 941)
|
(4 936)
|
(4 544)
|
(2 912)
|
(2 134)
|
(2 134)
|
267
|
407
|
0
|
0
|
0
|
709
|
0
|
|
| Pre-Tax Income |
66 075
N/A
|
76 581
+16%
|
84 134
+10%
|
87 276
+4%
|
86 236
-1%
|
87 223
+1%
|
78 945
-9%
|
74 448
-6%
|
79 269
+6%
|
77 056
-3%
|
90 242
+17%
|
97 031
+8%
|
109 729
+13%
|
115 620
+5%
|
117 810
+2%
|
121 449
+3%
|
129 217
+6%
|
150 234
+16%
|
184 395
+23%
|
207 893
+13%
|
233 687
+12%
|
253 677
+9%
|
274 453
+8%
|
298 188
+9%
|
291 213
-2%
|
319 878
+10%
|
353 995
+11%
|
419 385
+18%
|
541 351
+29%
|
545 049
+1%
|
807 309
+48%
|
531 166
-34%
|
731 541
+38%
|
744 822
+2%
|
470 347
-37%
|
443 821
-6%
|
444 048
+0%
|
488 855
+10%
|
540 217
+11%
|
543 034
+1%
|
578 974
+7%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(18 258)
|
(23 133)
|
(24 048)
|
(24 923)
|
(24 009)
|
(23 645)
|
(21 472)
|
(20 076)
|
(20 864)
|
(18 169)
|
(21 721)
|
(23 490)
|
(26 760)
|
(29 566)
|
(31 248)
|
(28 370)
|
(29 260)
|
(36 947)
|
(44 792)
|
(50 333)
|
(59 625)
|
(63 080)
|
(71 864)
|
(83 455)
|
(80 603)
|
(89 301)
|
(97 533)
|
(116 390)
|
(153 991)
|
(156 037)
|
(232 365)
|
(156 737)
|
(211 233)
|
(213 699)
|
(133 602)
|
(118 349)
|
(117 676)
|
(133 816)
|
(153 254)
|
(155 717)
|
(168 825)
|
|
| Income from Continuing Operations |
47 817
|
53 448
|
60 086
|
62 353
|
62 227
|
63 578
|
57 473
|
54 372
|
58 405
|
58 887
|
68 521
|
73 541
|
82 969
|
86 054
|
86 562
|
93 079
|
99 957
|
113 287
|
139 603
|
157 560
|
174 062
|
190 597
|
202 589
|
214 733
|
210 610
|
230 577
|
256 462
|
302 995
|
387 360
|
389 012
|
574 944
|
374 429
|
520 308
|
531 123
|
336 745
|
325 472
|
326 372
|
355 039
|
386 963
|
387 317
|
410 149
|
|
| Income to Minority Interest |
(1 030)
|
(1 227)
|
(1 189)
|
(1 228)
|
(1 184)
|
(1 040)
|
(908)
|
(780)
|
(811)
|
(744)
|
(817)
|
(827)
|
(868)
|
(767)
|
(704)
|
(591)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
46 786
N/A
|
52 220
+12%
|
58 897
+13%
|
61 125
+4%
|
61 043
0%
|
62 537
+2%
|
56 562
-10%
|
53 592
-5%
|
57 592
+7%
|
58 142
+1%
|
67 704
+16%
|
72 713
+7%
|
82 101
+13%
|
85 287
+4%
|
85 858
+1%
|
92 488
+8%
|
99 632
+8%
|
113 071
+13%
|
139 544
+23%
|
157 560
+13%
|
174 063
+10%
|
190 598
+9%
|
202 590
+6%
|
214 733
+6%
|
210 611
-2%
|
230 578
+9%
|
256 463
+11%
|
302 995
+18%
|
387 360
+28%
|
389 012
+0%
|
574 944
+48%
|
374 429
-35%
|
520 307
+39%
|
531 122
+2%
|
336 745
-37%
|
325 472
-3%
|
326 373
+0%
|
355 040
+9%
|
386 963
+9%
|
387 317
+0%
|
410 149
+6%
|
|
| EPS (Diluted) |
28.54
N/A
|
31.84
+12%
|
35.9
+13%
|
37.26
+4%
|
37.2
0%
|
38.11
+2%
|
34.47
-10%
|
32.66
-5%
|
35.09
+7%
|
35.42
+1%
|
41.23
+16%
|
44.28
+7%
|
49.97
+13%
|
51.9
+4%
|
52.24
+1%
|
56.27
+8%
|
60.6
+8%
|
68.76
+13%
|
84.85
+23%
|
95.81
+13%
|
105.83
+10%
|
115.87
+9%
|
123.15
+6%
|
130.53
+6%
|
128.02
-2%
|
140.16
+9%
|
155.89
+11%
|
184.17
+18%
|
235.44
+28%
|
236.44
+0%
|
349.45
+48%
|
227.57
-35%
|
316.23
+39%
|
322.8
+2%
|
204.65
-37%
|
197.8
-3%
|
198.34
+0%
|
215.75
+9%
|
235.11
+9%
|
235.36
+0%
|
249.23
+6%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
